Neuronetics Major Shareholder Buys $615,960 in Stock

Jorey Chernett, a major shareholder, increases stake in the medical technology company.

Mar. 21, 2026 at 9:07am

Got story updates? Submit your updates here. ›

Neuronetics, Inc. (NASDAQ:STIM) major shareholder Jorey Chernett acquired 531,000 shares of the company's stock in a transaction on Tuesday, March 17th. The shares were purchased at an average cost of $1.16 per share, for a total transaction of $615,960.00. Following the completion of the purchase, Chernett now directly owns 7,516,404 shares of the company's stock, valued at approximately $8,719,028.64.

Why it matters

This insider buying activity by a major shareholder suggests confidence in Neuronetics' future prospects. As a medical technology company focused on non-invasive neuromodulation therapies, Neuronetics' performance is closely watched by investors.

The details

Chernett's purchase represents a 7.60% increase in his stake in Neuronetics. Major shareholders that own at least 10% of a company's stock are required to disclose their sales and purchases with the SEC. Neuronetics' stock has traded in the range of $0.80 to $5.05 over the past year, and currently has a market cap of $100.45 million.

  • The transaction took place on Tuesday, March 17th, 2026.

The players

Jorey Chernett

A major shareholder of Neuronetics, Inc. who directly owns 7,516,404 shares of the company's stock following this latest purchase.

Neuronetics, Inc.

A commercial-stage medical technology company that develops and markets non-invasive neuromodulation therapies for psychiatric and neurological disorders, including its flagship product, the NeuroStar Advanced Therapy System.

Got photos? Submit your photos here. ›

The takeaway

This insider buying activity by a major shareholder in Neuronetics suggests confidence in the company's future prospects as it continues to develop and market its non-invasive neuromodulation therapies.